Literature DB >> 11525265

A radioimmunoassay for type I iodothyronine 5'-monodeiodinase in human tissues.

L Sabatino1, I J Chopra, S Tanavoli, P Iacconi, G Iervasi.   

Abstract

We have developed a sensitive, specific and reproducible radioimmunoassay (RIA) for measurement of human type I monodeiodinase (5'-DI) protein. Anti-5'-DI antibody was produced by immunization of rabbits with a conjugate of bovine serum albumin and a 16 amino acid synthetic peptide, corresponding to a portion of the carboxy-terminal region of the human 5'-DI (PI-99). In a final dilution of 1:500, our anti-5'-DI antibody bound about 30%-35% of a tracer amount of 125I-PI-99. The detection threshold of the RIA approximated 0.4 pmol PI-99 or an equivalent amount of 0.4 pmol 5'-DI. The coefficient of variation averaged 5% within an assay and 14% between assays. Dose-response curves of tissue proteins were essentially parallel to that of PI-99. In a total number of 35 normal human tissue samples, the mean (+/- standard deviation [SD], picomole per milligram of protein [pmol]) 5'-DI content was 25 +/- 6.7 in kidney, it was significantly lower (p < 0.05) in liver at 3.9 +/- 1.1, 2.8 +/- 0.8 in intestine, 2.3 +/- 0.98 in adrenal, 4.2 +/- 2.5 in skeletal muscle, 3.8 +/- 1.4 in heart and 2.6 +/- 2.4 in thyroid; it was 1.4 +/- 0.3 in Graves' thyroid. Our data suggest that (1) 5'-DI is distributed widely among human tissues; (2) kidney is the tissue most enriched with 5'-DI; (3) 5'-DI content in the thyroid is not increased in Graves' disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525265     DOI: 10.1089/10507250152484565

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  2 in total

1.  Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones.

Authors:  Laura Sabatino; Valter Lubrano; Silvana Balzan; Claudia Kusmic; Serena Del Turco; Giorgio Iervasi
Journal:  Mol Cell Biochem       Date:  2014-10-11       Impact factor: 3.396

2.  Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.

Authors:  Xinke Zhao; Rongcheng Zhang; Hugang Jiang; Kai Liu; Chengxu Ma; Ming Bai; Tao An; Younan Yao; Xinqiang Wang; Ming Wang; Yingdong Li; Yuhui Zhang; Jian Zhang
Journal:  BMC Endocr Disord       Date:  2021-07-02       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.